|
ZMYM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.51239087498834E-13 |
| Normal-vs-Stage2 |
3.81670000049183E-08 |
| Normal-vs-Stage3 |
1.12132525487141E-14 |
| Normal-vs-Stage4 |
3.53828077948037E-12 |
| Stage1-vs-Stage2 |
7.260200E-01 |
| Stage1-vs-Stage3 |
8.903900E-02 |
| Stage1-vs-Stage4 |
2.802300E-02 |
| Stage2-vs-Stage3 |
3.874600E-01 |
| Stage2-vs-Stage4 |
2.362400E-01 |
| Stage3-vs-Stage4 |
6.104400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55431223447522E-15 |
| Normal-vs-AfricanAmerican |
1.151700E-04 |
| Normal-vs-Asian |
3.19880011367957E-10 |
| Caucasian-vs-AfricanAmerican |
3.604800E-01 |
| Caucasian-vs-Asian |
6.960400E-01 |
| AfricanAmerican-vs-Asian |
2.602800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50559597911615E-13 |
| Normal-vs-Female |
1.62592161956354E-12 |
| Male-vs-Female |
8.227000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.39686048786325E-12 |
| Normal-vs-Age(41-60Yrs) |
2.90534263314157E-12 |
| Normal-vs-Age(61-80Yrs) |
1.81676895749661E-12 |
| Normal-vs-Age(81-100Yrs) |
2.574000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.030600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.009600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.877400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.287000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.479600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.951800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.044000E-04 |
| Classical-VS-Follicular |
5.596200E-01 |
| Classical-VS-Other |
7.261400E-01 |
| Classical-VS-Normal |
1.29230004475289E-09 |
| Tall-VS-Follicular |
1.349640E-02 |
| Tall-VS-Other |
1.370650E-01 |
| Tall-VS-Normal |
1.77347025953623E-12 |
| Follicular-VS-Other |
9.395000E-01 |
| Follicular-VS-Normal |
1.63769999783625E-08 |
| Other-VS-Normal |
4.135100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.93969318174459E-14 |
| Normal-vs-N1 |
2.5730995112383E-10 |
| N0-vs-N1 |
7.060600E-01 |
|
|
